세계의 지속적신대체요법(CRRT) 시장 규모 조사 및 예측 : 제품별, 모달리티별, 연령층별, 최종사용자별, 지역별 분석(2023-2030년)

Global Continuous Renal Replacement Therapy Market is valued at approximately USD 1.3 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.1% during the forecast period 2023-2030. Continuous Renal Replacement Therapy (CRRT) is a crucial intervention in managing renal function for critically ill patients facing Acute Kidney Injury (AKI). This method provides a continuous 24-hour dialysis therapy that is particularly beneficial for patients experiencing hemodynamic instability. CRRT involves the gradual removal of solutes from the blood through processes such as hemofiltration, hemodialysis, or a combination of both, and it is administered continuously within an ICU setting, distinguishing it from conventional renal replacement therapies. The market for CRRT has witnessed significant growth due to factors such as the increasing ICU admissions globally, a surge in sepsis-related AKI cases, the growing clinical advantage of CRRT over intermittent blood purification, and the rising prevalence of diabetes and hypertension.

In addition, the rising number of patients in critical care units globally, particularly those experiencing Acute Kidney Injury (AKI) is primarily supporting the market growth. AKI is a prevalent concern in Intensive Care Units (ICUs), and CRRT has proven impactful in managing critically ill patients with this complication. For instance, recent data from the Centers for Disease Control and Prevention (CDC) indicates that around 1.7 million adults in the U.S. develop sepsis, contributing to a high demand for CRRT as a vital component in managing sepsis-associated AKI with its associated morbidity and mortality rates. Also, a National Center for Biotechnology Information (NCBI) article from October 2020 states that between 13% and 18% of hospitalized patients in the United Kingdom suffer from acute renal damage. The therapy is primarily administered to patients with severe conditions such as cancer, diabetes, and cardiac surgery, providing crucial support for 24 hours or longer, depending on the patient's medical condition. According to the Department of Economic and Social Affairs, in 2019, the world's population of people aged 65 and up totalled 703 million. Also, the number of elderly people is expected to increase to 1.5 billion by 2050. The prevalence of AKI and the growing geriatric population worldwide contribute to the increasing demand for CRRT. The surge in ICU admissions due to age-related health conditions, such as hypertension, cancer, heart disease, diabetes, and stroke, highlights the therapy's importance in managing acute and chronic health issues. The projected rise in the global aging population further emphasizes the expanding role of CRRT in meeting healthcare needs. These factors collectively drive the continuous expansion of the CRRT Market. Moreover, the development of CRRT from simple renal replacement treatment to multi-organ support therapy, as well as the rising emphasis on the research activities to establish the safety and efficacy profile of CRRT presents various lucrative opportunities over the forecast years. However, the lack of standard treatment guidelines in developing nations and the high complexity of CRRT are hindering market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Continuous Renal Replacement Therapy Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the high prevalence of Acute Kidney Injury (AKI) among Intensive Care Unit (ICU) patients, robust demand for therapy-related products surpassing other regions, and the presence of well-established healthcare infrastructure. Furthermore, the region benefits from increasing support from regulatory bodies, and the strong presence of product manufacturers contributes to its significant market share. For instance, in April 2022, Baxter International Inc. obtained the 510(k) clearance from the U.S. Food and Drug Administration for its ST Set utilized in this therapy, compatible with PrisMax or Prismaflex control units. Whereas, Asia Pacific is expected to grow at the fastest CAGR over the forecast years. The rising incidence rates of diabetes, Chronic Kidney Disease (CKD), and hypertension are significantly propelling the market demand across the region. Additionally, increased healthcare expenditure and growing research and development investments contribute to the flourishing healthcare market, which is further supporting the market expansion over the anticipated years.

Major market players included in this report are:

• Baxter
• B Braun SE
• Fresenius Medical Care AG & Co. KGaA
• Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
• NIPRO Corporation (
• Toray Medical Co, Ltd. (Toray Industries, Inc.)
• Nikkiso Co., Ltd.
• Medtronic PLC
• Medica SpA
• Medical Components, Inc.

Recent Developments in the Market:

• In March 2022, Nipro, a prominent manufacturer of renal products, unveiled the full-scale commercial launch of SURDIAL DX, a cutting-edge hemodialysis system meticulously crafted to deliver optimal dialysis treatment.
• In April 2022, Baxter International announced that the ST set used in continuous renal replacement treatment has received FDA (510k) approval. This pre-configured extracorporeal device works in perfect harmony with Prismaflex or PrisMax, using a semipermeable membrane to cleanse blood..
• In August 2022, Fresenius Medical Care North America launched the Speedswap system designed for use with the NxStage System One featuring NxView. This innovation aims to minimize downtime, decrease treatment costs, and alleviate nursing burdens associated with this therapy in critical care settings.

Global Continuous Renal Replacement Therapy Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Modality, Age Group, End User, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Dialysates and Replacement Fluids
• Disposables
• Hemofilters
• Bloodline Sets & Tubes
• Other Disposables
• CRRT Systems

By Modality:

• Continuous venovenous hemofiltration (CVVH)
• Continuous venovenous hemodiafiltration (CVVHDF)
• Continuous venovenous haemodialysis (CVVHD)
• Slow continuous ultrafiltration (SCUF)

By Age Group:

• Adults
• Pediatrics /Neonates

By End User:

• Hospital
• Ambulatory care
• Homecare
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Continuous Renal Replacement Therapy Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Continuous Renal Replacement Therapy Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3. Continuous Renal Replacement Therapy Market, by Modality, 2020-2030 (USD Billion)
  • 1.2.4. Continuous Renal Replacement Therapy Market, by Age Group, 2020-2030 (USD Billion)
  • 1.2.5. Continuous Renal Replacement Therapy Market, by End User, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Continuous Renal Replacement Therapy Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Continuous Renal Replacement Therapy Market Dynamics

• 3.1. Continuous Renal Replacement Therapy Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of Acute Kidney Injury (AKI)
    • 3.1.1.2. Growing clinical advantage of CRRT over intermittent blood purification
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of standard treatment guidelines in developing nations
    • 3.1.2.2. High complexity of CRRT
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Development of CRRT from simple renal replacement treatment to multi-organ support therapy
    • 3.1.3.2. Rising emphasis on the research activities to establish safety and efficacy profile of CRRT

Chapter 4. Global Continuous Renal Replacement Therapy Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Continuous Renal Replacement Therapy Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Continuous Renal Replacement Therapy Market by Product, Performance - Potential Analysis
• 5.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
  • 5.4.1. Dialysates and Replacement Fluids
  • 5.4.2. Disposables
  • 5.4.3. Hemofilters
  • 5.4.4. Bloodline Sets & Tubes
  • 5.4.5. Other Disposables
  • 5.4.6. CRRT Systems

Chapter 6. Global Continuous Renal Replacement Therapy Market, by Modality

• 6.1. Market Snapshot
• 6.2. Global Continuous Renal Replacement Therapy Market by Modality, Performance - Potential Analysis
• 6.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
• 6.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
  • 6.4.1. Continuous venovenous hemofiltration (CVVH)
  • 6.4.2. Continuous venovenous hemodiafiltration (CVVHDF)
  • 6.4.3. Continuous venovenous haemodialysis (CVVHD)
  • 6.4.4. Slow continuous ultrafiltration (SCUF)

Chapter 7. Global Continuous Renal Replacement Therapy Market, by Age Group

• 7.1. Market Snapshot
• 7.2. Global Continuous Renal Replacement Therapy Market by Age Group, Performance - Potential Analysis
• 7.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
• 7.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
  • 7.4.1. Adults
  • 7.4.2. Pediatrics /Neonates

Chapter 8. Continuous Renal Replacement Therapy Market, by End User

• 8.1. Market Snapshot
• 8.2. Global Continuous Renal Replacement Therapy Market by End User, Performance - Potential Analysis
• 8.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
• 8.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
  • 8.4.1. Hospital
  • 8.4.2. Ambulatory care
  • 8.4.3. Homecare
  • 8.4.4. Others

Chapter 9. Global Continuous Renal Replacement Therapy Market, Regional Analysis

• 9.1. Top Leading Countries
• 9.2. Top Emerging Countries
• 9.3. Continuous Renal Replacement Therapy Market, Regional Market Snapshot
• 9.4. North America Continuous Renal Replacement Therapy Market
  • 9.4.1. U.S. Continuous Renal Replacement Therapy Market
    • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2. Modality breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3. Age Group breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4. End User breakdown estimates & forecasts, 2020-2030
  • 9.4.2. Canada Continuous Renal Replacement Therapy Market
• 9.5. Europe Continuous Renal Replacement Therapy Market Snapshot
  • 9.5.1. U.K. Continuous Renal Replacement Therapy Market
  • 9.5.2. Germany Continuous Renal Replacement Therapy Market
  • 9.5.3. France Continuous Renal Replacement Therapy Market
  • 9.5.4. Spain Continuous Renal Replacement Therapy Market
  • 9.5.5. Italy Continuous Renal Replacement Therapy Market
  • 9.5.6. Rest of Europe Continuous Renal Replacement Therapy Market
• 9.6. Asia-Pacific Continuous Renal Replacement Therapy Market Snapshot
  • 9.6.1. China Continuous Renal Replacement Therapy Market
  • 9.6.2. India Continuous Renal Replacement Therapy Market
  • 9.6.3. Japan Continuous Renal Replacement Therapy Market
  • 9.6.4. Australia Continuous Renal Replacement Therapy Market
  • 9.6.5. South Korea Continuous Renal Replacement Therapy Market
  • 9.6.6. Rest of Asia Pacific Continuous Renal Replacement Therapy Market
• 9.7. Latin America Continuous Renal Replacement Therapy Market Snapshot
  • 9.7.1. Brazil Continuous Renal Replacement Therapy Market
  • 9.7.2. Mexico Continuous Renal Replacement Therapy Market
• 9.8. Middle East & Africa Continuous Renal Replacement Therapy Market
  • 9.8.1. Saudi Arabia Continuous Renal Replacement Therapy Market
  • 9.8.2. South Africa Continuous Renal Replacement Therapy Market
  • 9.8.3. Rest of Middle East & Africa Continuous Renal Replacement Therapy Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
  • 10.1.1. Company 1
  • 10.1.2. Company 2
  • 10.1.3. Company 3
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Baxter
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Recent Developments
  • 10.3.2. B Braun SE
  • 10.3.3. Fresenius Medical Care AG & Co. KGaA
  • 10.3.4. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
  • 10.3.5. NIPRO Corporation
  • 10.3.6. Toray Medical Co, Ltd. (Toray Industries, Inc.)
  • 10.3.7. Nikkiso Co., Ltd.
  • 10.3.8. Medtronic PLC
  • 10.3.9. Medica SpA
  • 10.3.10. Medical Components, Inc.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption